| Presence | Participants | Cancer deaths | Parson-years | Crude mortality (/1000 person-years) | HR-agea (95% CI) | HR-allb (95% CI) |
---|---|---|---|---|---|---|---|
Men | |||||||
 Obesity | No | 3484 | 378 | 62,224 | 6.1 | 1.00 | 1.00 |
Yes | 1011 | 95 | 18,602 | 5.1 | 0.97 (0.77–1.21) | 0.99 (0.78–1.26) | |
 Elevated blood pressure | No | 2053 | 191 | 37,693 | 5.1 | 1.00 | 1.00 |
Yes | 2442 | 282 | 43,150 | 6.5 | 0.96 (0.80–1.16) | 0.99 (0.82–1.21) | |
 Elevated plasma glucose | No | 3833 | 378 | 69,607 | 5.4 | 1.00 | 1.00 |
Yes | 662 | 95 | 11,247 | 8.4 | 1.46 (1.17–1.83) | 1.49 (1.18–1.88) | |
 Dyslipidemia | No | 2676 | 280 | 48,221 | 5.8 | 1.00 | 1.00 |
Yes | 1819 | 193 | 32,633 | 5.9 | 1.15 (0.96–1.38) | 1.10 (0.91–1.34) | |
Women | |||||||
 Obesity | No | 5245 | 195 | 98,606 | 2.0 | 1.00 | 1.00 |
Yes | 1783 | 102 | 33,717 | 3.0 | 1.44 (1.14–1.83) | 1.48 (1.15–1.91) | |
 Elevated blood pressure | No | 3657 | 127 | 69,337 | 1.8 | 1.00 | 1.00 |
Yes | 3371 | 170 | 63,004 | 2.7 | 1.04 (0.82–1.31) | 1.02 (0.80–1.31) | |
 Elevated plasma glucose | No | 6403 | 256 | 120,761 | 2.1 | 1.00 | 1.00 |
Yes | 625 | 41 | 11,556 | 3.5 | 1.37 (0.98–1.91) | 1.44 (1.03–2.03) | |
 Dyslipidemia | No | 5143 | 208 | 96,688 | 2.2 | 1.00 | 1.00 |
Yes | 1885 | 89 | 35,664 | 2.5 | 1.03 (0.80–1.31) | 1.04 (0.80–1.34) |